Publication | Closed Access
STAT3 Mediates Nilotinib Response in KIT-Altered Melanoma: A Phase II Multicenter Trial of the French Skin Cancer Network
57
Citations
40
References
2017
Year
OncologyKit-altered MelanomaMedicineMelanomaImmune Checkpoint InhibitorDermatologyCancer BiologyCell BiologyTumor BiologySkin Cancer
| Year | Citations | |
|---|---|---|
Page 1
Page 1